| ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion A Chronopoulos, B Robinson, M Sarper, E Cortes, V Auernheimer, ... Nature communications 7 (1), 12630, 2016 | 246 | 2016 |
| Emerging role of bacterial extracellular vesicles in cancer A Chronopoulos, R Kalluri Oncogene 39 (46), 6951-6960, 2020 | 147 | 2020 |
| Substrate rigidity controls activation and durotaxis in pancreatic stellate cells D Lachowski, E Cortes, D Pink, A Chronopoulos, SA Karim, J P. Morton, ... Scientific reports 7 (1), 2506, 2017 | 131 | 2017 |
| Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer KM McAndrews, F Xiao, A Chronopoulos, VS LeBleu, FG Kugeratski, ... Life science alliance 4 (9), 2021 | 114 | 2021 |
| Syndecan-4 tunes cell mechanics by activating the kindlin-integrin-RhoA pathway A Chronopoulos, SD Thorpe, E Cortes, D Lachowski, AJ Rice, ... Nature materials 19 (6), 669-678, 2020 | 90 | 2020 |
| GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment E Cortes, M Sarper, B Robinson, D Lachowski, A Chronopoulos, ... EMBO reports 20 (1), e46556, 2019 | 69 | 2019 |
| Liquid biopsies for management of pancreatic cancer M Samandari, MG Julia, A Rice, A Chronopoulos, AE del Rio Hernandez Translational Research 201, 98-127, 2018 | 67 | 2018 |
| SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer Y Perone, AJ Farrugia, A Rodríguez-Meira, B Győrffy, C Ion, A Uggetti, ... Nature communications 10 (1), 2115, 2019 | 59 | 2019 |
| Retinoic acid receptor‐β is downregulated in hepatocellular carcinoma and cirrhosis and its expression inhibits myosin‐driven activation and durotaxis in hepatic stellate cells E Cortes, D Lachowski, A Rice, A Chronopoulos, B Robinson, S Thorpe, ... Hepatology 69 (2), 785-802, 2019 | 57 | 2019 |
| Exosomes as a platform for ‘liquid biopsy’in pancreatic cancer A Chronopoulos, TJ Lieberthal, AE del Río Hernández Convergent Science Physical Oncology 3 (1), 013005, 2017 | 12 | 2017 |
| Pancreatic cancer: a mechanobiology approach A Chronopoulos, TJ Lieberthal, AE del Río Hernández Convergent Science Physical Oncology 3 (1), 013001, 2017 | 10 | 2017 |
| RAR-beta is downregulated in HCC & cirrhosis and its expression inhibits myosin-driven activation and durotaxis in hepatic stellate cells E Cortes, D Lachowski, A Rice, A Chronopoulos, B Robinson, S Thorpe, ... Hepatology 10, 2018 | 8 | 2018 |
| ALK upregulates POSTN and WNT signaling to drive neuroblastoma M Huang, W Fang, A Farrel, L Li, A Chronopoulos, N Nasholm, B Cheng, ... Cell reports 43 (3), 2024 | 1 | 2024 |
| Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma D Lascano, MJ Zobel, WG Lee, SY Chen, A Zamora, GE Asuelime, ... Scientific Reports 13 (1), 19915, 2023 | 1 | 2023 |
| Differential cell-ECM interaction of rhabdomyosarcoma subtypes regulated by PAX3-FOXO1 A Chronopoulos, I Chavez, C Vemula, N Mittal, V Zamloot, SJ Han, ... bioRxiv, 2024.06. 11.598505, 2024 | | 2024 |
| Extracellular matrix topography drives adrenergic to mesenchymal transition in neuroblastoma A Chronopoulos, C Vemula, I Chavez, R Kennedy, S Asgharzadeh, ... bioRxiv, 2023.10. 10.561780, 2023 | | 2023 |
| Using vitamin A to target early and late liver diseases via mechanotransduction E Cortes, D Lachowski, A Rice, A Chronopoulos, B Robinson, S Thorpe, ... | | 2019 |
| Mechanotransduction in health and disease A Chronopoulos Imperial College London, 2018 | | 2018 |
